Australia to India: Guaifenesin Import Trade Route

The Australia to India Guaifenesin corridor is one of India's established pharmaceutical import routes from Australia, with 2 shipments documented worth a combined $2 USD. The route is dominated by AUSTRALIAN PHARMACEUTICAL , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Australia's guaifenesin export sector.

Across 1 active Australia suppliers, the average shipment value stands at $1 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with guaifenesin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 12.8%, placing it at rank #1 among India's top guaifenesin import origins globally.

On the Indian buyer side, key Indian importers include GRACURE PHARMACEUTICALS LIMITED . GRACURE PHARMACEUTICALS LIMITED is the single largest Indian importer with 2 shipments valued at $2 USD.

India's guaifenesin imports from Australia are driven primarily by a handful of large-scale Australia manufacturers. AUSTRALIAN PHARMACEUTICAL with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Australia supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AUSTRALIAN PHARMACEUTICAL — together account for 100% of total trade value on this route. The average shipment value of $1 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as bromhexine and guaifenesin placebo (01 unit x 200ml) (r & d purpose) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Australia supplier.

On the buying side, GRACURE PHARMACEUTICALS LIMITED is the largest importer with 2 shipments worth $2 USD — representing 100% of all guaifenesin imports from Australia on this route.